All Live and On-Demand Activities
Filter Activities
Ushering in A New Wave of Progress in Advanced Hepatobiliary Cancers: Expert Perspectives on Incorporating New Evidence and Innovative Therapeutics to Deliver Optimal, Patient-Centered Care
0.25 hr(s) | NCPD
Specialty: Hepatobiliary Cancers
Therapeutic Area(s): Oncology
Release Date: September 27, 2021
Expiration Date: September 26, 2022
Location: Internet Activity Enduring
After more than a decade of limited progress, the clinical management of advanced biliary tract cancers is rapidly changing. The introduction of new systemic therapies and the increased understanding of clinically actionable mutations in biliary tract cancers have led to the development of several biomarker-guided treatments and other promising strategies. In this activity, an oncology advanced practice provider discusses the latest clinical data regarding recently validated and forthcoming therapeutic strategies for patients with biliary tract cancers and the nurse’s role in improving patient outcomes through patient education, monitoring for and managing treatment-related toxicities, and counseling patients on therapeutic options, including clinical trial enrollment.
Across the Age Spectrum: Expert Insights on Emerging Uses of Targeted Therapy for the Treatment of Uncontrolled Moderate-to-Severe Asthma
0.50 hr(s) | CME
Specialty: Asthma
Therapeutic Area(s): Pulmonology
Release Date: September 27, 2021
Expiration Date: September 26, 2022
Location: Internet Activity Enduring
In this activity, an expert in pulmonology discusses the latest clinical research and treatment guidelines on approved biologic therapies for the management of adult and pediatric patients with uncontrolled moderate to severe asthma.
Secondary AML Through the Microscope: A Pathology-informed Guide to Modern Diagnostic and Treatment Principles
0.50 hr(s) | ABIM , ABPath , CC , CME , MOC
Specialty: AML
Therapeutic Area(s): Hematology, Malignant , Oncology
Release Date: September 20, 2021
Expiration Date: September 19, 2022
Location: Internet Activity Enduring
In this activity, an expert pathologist discusses secondary acute myeloid leukemia (AML) as well as the modern tools used in diagnostic assessment that can help facilitate appropriate risk stratification and collaborative treatment decisions so therapies beyond conventional chemotherapy options can be considered.
Test Your Knowledge of New and Emerging Therapies for Moderate-to-Severe Atopic Dermatitis: Latest Evidence and Clinical Potential
0.50 hr(s) | CME , NCPD
Specialty: Atopic Dermatitis
Therapeutic Area(s): Dermatology
Release Date: September 17, 2021
Expiration Date: September 16, 2022
Location: Internet Activity Enduring
In this activity, an expert in dermatology discusses new and emerging therapies for patients with moderate to severe atopic dermatitis.
Visualizing the Present and Future of CLL: How Innovative Therapies and State-of-the-Art Combinations are Transforming Patient Care
0.50 hr(s) | CME
Specialty: Chronic Lymphocytic Leukemia (CLL)
Therapeutic Area(s): Chronic Lympoblastic Leukemia (CLL) , Hematology, Malignant , Oncology
Release Date: September 7, 2021
Expiration Date: September 6, 2022
Location: Internet Activity Enduring
Modern management of chronic lymphocytic leukemia (CLL) has been transformed by innovative therapeutics, including BTK and BCL-2 inhibitors, in a range of patient populations and treatment settings—but what is the next step? In this activity, an expert clinician addresses that question and reviews evidence on emerging targeted options and novel combination strategies likely to affect patient care.
A Personalized Approach to Guide Risk-Adapted Treatment Decisions in Myelofibrosis: Applying the Latest Clinical Evidence on JAK Inhibitors and Novel Combination Therapies to Improve Patient Outcomes
0.50 hr(s) | ABIM , CME , MOC , Royal College of Physicians and Surgeons of Canada
Specialty: Myelofibrosis
Therapeutic Area(s): Oncology
Release Date: August 25, 2021
Expiration Date: August 24, 2022
Location: Internet Activity Enduring
In this activity, hematology-oncology experts discuss the current and emerging therapeutic options for the management of patients with myelofibrosis.
Taking the Fight to AML: Oncology Nurse Perspectives, Principles, and Practice in an Era of Innovative Therapies
1.00 hr(s) | ILNA , NCPD
Specialty: AML
Release Date: August 18, 2021
Expiration Date: August 17, 2022
Location: Internet Activity Enduring
In this activity, two expert nurse panelists use case-based teaching to illustrate solutions to clinical challenges associated with nursing care in the modern acute myeloid leukemia (AML) treatment landscape in which innovative therapies (including targeted agents, newer cytotoxics, and epigenetic approaches) are now core patient treatment strategies.
Examining Novel Approaches to Improve the Management of Influenza: An Animated Exploration
0.50 hr(s) | ABIM , ABP , CME , MOC , NCPD
Specialty: Influenza
Therapeutic Area(s): Immunology
Release Date: July 21, 2021
Expiration Date: July 20, 2022
Location: Internet Activity Enduring
In this activity, an influenza expert discusses the latest clinical evidence and current guideline recommendations on the use of antiviral therapy in the treatment of influenza.
Determining Which Patients Will Benefit from GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM
0.50 hr(s) | CME
Specialty: Diabetes
Therapeutic Area(s): Endocrinology
Release Date: July 16, 2021
Expiration Date: July 15, 2022
Location: Internet Activity Enduring
In this activity, an expert on type 2 diabetes mellitus (T2DM) discusses how GLP-1 RAs can be integrated into individualized treatment plans to improve outcomes for patients with T2DM.
Demystifying the Role of Incretin-Based Weight Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity
0.500 hr(s) | CME
Therapeutic Area(s): Endocrinology
Release Date: July 15, 2021
Expiration Date: July 14, 2022
Location: Internet Activity Enduring
In this animated activity, an expert in obesity reviews current evidence for incretin-based weight-loss pharmacotherapy and offers evidence-based approaches to individualizing care for patients with obesity.